Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

NCT05672654 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Responsibility for registering this study lies with the sponsor, DiaSorin, and not with our institution

Conditions

Interventions

Sponsor

University Hospital, Ghent